Company Shares of Boston Scientific Corporation (NYSE:BSX) Drops by -4.86%

(Source: News Watch International) During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral …